What is the CRVS stock price prediction for next 2 weeks?

According to our price prediction algorithm,Corvus Pharmaceuticals, Inc. (CRVS) price will be around $10.99 in the next 2 weeks. This means it will decrease by -14.94659442724459 from the last closing price. This prediction may vary from other time period filters for CRVS stock.

What can be the highest Possible price of CRVS stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, CRVS can achieve the highest price of $11.65 which is -9.802181657029186 lower than last closing price. This prediction may vary from other time period filters for CRVS stock.

What can be the lowest Possible price of CRVS stock in next 2 weeks?

As per the forecast and algorithmic analysis, CRVS stock price can be as low as $10.41 which is -19.43288308710177 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for CRVS stock.

Will CRVS stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that CRVS stock will lose-14.94659442724459 in the next 2 weeks. This prediction may vary from other time period filters for CRVS stock.

What is CRVS stock last closing price?

Last closing price of CRVS stock was $12.92.

What is CRVS stock price prediction?

CRVS stock price prediction means predicting the future closing prices of CRVS stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of CRVS stock in a certain time period.

How we predict CRVS stock future prices?

If you are searching for CRVS stock forecast, analysis or price prediction, then you might be wondering what Corvus Pharmaceuticals, Inc. (CRVS) will do in the future. Our CRVS price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This CRVS price prediction will likely answer most of your questions.

How frequent we update CRVS stock predictions?

We are updating the forecasts for the CRVS stock on daily basis.

Is using ML forecasting for CRVS stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for CRVS stock same for all the time periods?

No, the prediction for CRVS stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Corvus Pharmaceuticals, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$12.92-13.69%Since 2 Weeks

Predicted Price$10.99-14.95%For 2 Weeks

Upper Predicted Price$11.65-9.8%For 2 Weeks

Lower Predicted Price$10.41-19.43%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of CRVS will decline by -14.95% over the next 2 Weeks and hit $10.99 by Monday, August 10, 2026. In that time frame, CRVS's share price is expected to range between $10.41 and $11.65.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Aug 10, 2026	10.41	10.99	11.65
Aug 7, 2026	11.04	11.60	12.17
Aug 6, 2026	10.97	11.52	12.08
Aug 5, 2026	11.20	11.67	12.15
Aug 4, 2026	11.37	11.82	12.30
Aug 3, 2026	11.40	11.84	12.28
Jul 31, 2026	12.05	12.45	12.88
Jul 30, 2026	11.95	12.37	12.77
Jul 29, 2026	12.13	12.52	12.92
Jul 28, 2026	12.30	12.67	13.02

CRVS shares rose +3.02% in Tuesday, July 28, 2026's trading session, rising from a previous close of $12.92 to move at $13.31. The stock demonstrated notable intraday movement (see CRVS's key stats for a full breakdown), fluctuating between $12.53 and $13.34, a +6.46% trading range. While recent weeks have seen some volatility, CRVS has managed to secure a -11.09% drop over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 844.59K shares changing hands, 111.29K fewer than the previous session. This amounted to $11.24M in total market activity.

Will CRVS Continue Its Downward Trend?

According to analyst ratings and projections for CRVS, Corvus Pharmaceuticals, Inc. shares are anticipated to decrease by -14.21%, potentially reaching $11.65 per share by August 10, 2026. Short-term technical indicators currently suggest a neutral sentiment for CRVS. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the CRVS stock forecast, now is not the best time to buy CRVS stock because its current trading price is +21.12% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on CRVS covering social and institutional perspectives.

CRVS Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into CRVS's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 39.78% to 46.15%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 48.91%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 50.86%, maintains a neutral outlook for the long term. Insights into CRVS's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Corvus Pharmaceuticals Short-Term Forecasts

CRVS Forecast For Next 5 Days

Our algorithm anticipates Corvus Pharmaceuticals (CRVS) stock could hit $12.59 by Aug 04, 2026. This represents a -5.43% rise from today's price, following a +217.19% change over the past five days.

CRVS Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Corvus Pharmaceuticals, Inc. (CRVS) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $12.93, which would mean a -2.85% decrease from the current price of $13.31. Projections for this period range from a high of $16.36 to a low of $9.22.

CRVS Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Corvus Pharmaceuticals's price over the next three months point to a rise. CRVS stock is expected to peak at $29.14 on Oct 06, 2026 after potentially dipping to $15.95 on Aug 13, 2026. On average, CRVS is likely to trade around $22.87 in the coming 90 days.

Corvus Pharmaceuticals Stock Forecast 2025

Based on our predictive models, Corvus Pharmaceuticals (CRVS) is expected to trade between $15.95 and $35.57 throughout 2026. This would result in an average price of $24.88, potentially offering investors a +86.93% return from current levels.

Corvus Pharmaceuticals, Inc. Monthly Forecast 2026–2027

July 2026

According to our latest forecast models, Corvus Pharmaceuticals, Inc. (CRVS) is positioned to show a strong performance in July 2026. The price is predicted to move between $20.65 and $22.73, settling at an average of $21.59. This could translate to a +62.21% gain.

August 2026

Based on current market signals, Corvus Pharmaceuticals, Inc. is projected to trend august 2026. We forecast a trading range from $15.95 to $25.99, with a likely average price of $19.75. Investors could expect a potential return of +48.38%.

September 2026

Our predictive algorithms indicate Corvus Pharmaceuticals, Inc. stock may see a shift in September 2026. The expected range spans $23.19–$26.37, with an average target of $24.63. This represents a positive outlook and a possible gain of +85.05%.

October 2026

Analyzing established trends, Corvus Pharmaceuticals, Inc. looks set to move in October 2026. Projections place the stock between $20.57 and $29.14, averaging around $24.14. This suggests a +81.37% gain from current levels.

November 2026

Market indicators suggest Corvus Pharmaceuticals, Inc. could experience notable changes during November 2026. Prices could fluctuate within $18.88 to $35.57, with a midpoint forecast of $27.11. The stock might deliver a +103.68% gain.

December 2026

Forecasting for December 2026, models estimate that Corvus Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $20.00 and $34.98, averaging $29.05. This signals a positive trajectory with potential returns around +118.26%.

January 2027

According to our latest forecast models, Corvus Pharmaceuticals, Inc. (CRVS) is positioned to show a strong performance in January 2027. The price is predicted to move between $18.93 and $72.61, settling at an average of $39.10. This could translate to a +193.76% gain.

February 2027

Based on current market signals, Corvus Pharmaceuticals, Inc. is projected to trend february 2027. We forecast a trading range from $46.89 to $73.92, with a likely average price of $57.06. Investors could expect a potential return of +328.70%.

March 2027

Our predictive algorithms indicate Corvus Pharmaceuticals, Inc. stock may see a shift in March 2027. The expected range spans $29.26–$57.07, with an average target of $41.48. This represents a positive outlook and a possible gain of +211.65%.

April 2027

Analyzing established trends, Corvus Pharmaceuticals, Inc. looks set to move in April 2027. Projections place the stock between $27.41 and $56.49, averaging around $39.27. This suggests a +195.04% gain from current levels.

May 2027

Market indicators suggest Corvus Pharmaceuticals, Inc. could experience notable changes during May 2027. Prices could fluctuate within $31.97 to $48.87, with a midpoint forecast of $37.11. The stock might deliver a +178.81% gain.

June 2027

Forecasting for June 2027, models estimate that Corvus Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $22.68 and $39.47, averaging $27.02. This signals a positive trajectory with potential returns around +103.01%.

July 2027

According to our latest forecast models, Corvus Pharmaceuticals, Inc. (CRVS) is positioned to show a strong performance in July 2027. The price is predicted to move between $30.59 and $42.17, settling at an average of $32.92. This could translate to a +147.33% gain.

CRVS's history of dividends and stock splits also plays a role in long-term investor confidence.